Clinical trials
Completed COVID-19 trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
107 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 65 |
| 2021 | 25 |
| 2022 | 13 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 107 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| I.M. Sechenov First Moscow State Medical University | 8 |
| Promomed, LLC | 8 |
| Eurasian Association of Therapists | 4 |
| AstraZeneca | 3 |
| Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 3 |
| Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 3 |
| Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | 3 |
| NPO Petrovax | 3 |
| National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia | 3 |
| R-Pharm | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 107 |
| Coronavirus Infections | 23 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Atrial Fibrillation | 3 |
| Diabetes Mellitus | 3 |
| Hypertension | 3 |
| Lung Diseases | 3 |
| Pneumonia | 3 |
| Pneumonia, Viral | 3 |
| Severe Acute Respiratory Syndrome | 3 |
Trials
Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.
7 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.